Cenegermin OverviewCenegermin (planned brand names Oxervate, Sentinel), also known as recombinant human nerve growth factor (rhNGF), is a recombinant form of human nerve growth factor (NGF). It was approved in the European Union as an eye drop formulation for the treatment of moderate or severe neurotrophic keratitis in adults on 6 July 2017. As a recombinant form of NGF, cenegermin is a peripherally selective agonist of the TrkA and LNGFR (p75NTR) which...
Read more Cenegermin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cenegermin
Recent Cenegermin Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 0.002%(20mcg/ml)
Other drugs which contain Cenegermin or a similar ingredient: (1 result)
- OXERVATE Cenegermin-bkbj